-
The Intricate Web of MicroRNAs in Modulating EGFR-TKI Resistance in Non-Small Cell Lung Cancer: A Comprehensive Review
11 Nov 2025 07:13 GMT
… osimertinib resistance in lung cancer by inhibiting the … . Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma. N … sensitizing EGFR mutations in lung cancer activate anti-apoptotic … non-small cell lung cancer. Transl Lung Cancer Res. 2022;11 …
-
Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
24 Oct 2025 14:10 GMT
… lung cancer into non-small cell lung cancer (NSCLC) and small cell lung cancer … of lung cancer.
Current treatment modalities for lung cancer include … chemotherapeutic agents like cisplatin, paclitaxel, and docetaxel (DTX … CPT-NPs inhibited lung tumor growth by …
-
[ESMO 2025] Bivalent antibody ivonescimab shows potential as a 1st-line treatment for lung cancer
20 Oct 2025 05:30 GMT
… achieved significant results in a lung cancer study comparing it to Tevimbra … metastatic squamous non-small cell lung cancer (NSCLC), regardless of PD-L1 … groups received four cycles of paclitaxel (175 mg/m²) and …
-
Pulsed Low-Dose-Rate Chemoradiation Therapy Reduces Side Effects Without Compromising Efficacy in Esophageal and Non-Small Cell Lung Cancer Patients
30 Sep 2025 21:39 GMT
… and non-small cell lung cancers. This approach, termed … protocols employing carboplatin and paclitaxel. The regimen spanned … for esophageal and select lung cancer patient populations.
Further … induced esophagitisnon-small cell lung cancer therapypulsed low-dose- …
-
Immuneering Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates
12 Nov 2025 21:05 GMT
… with modified gemcitabine/nab-paclitaxel (mGnP) in first-line pancreatic … Libtayo in non-small cell lung cancer
Third Quarter 2025 Financial Highlights … , including modified Gemcitabine/nab-paclitaxel (mGnP) or FOLFIRINOX in first …
-
KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight
12 Nov 2025 18:00 GMT
… Cancer, Non-small Cell Lung Cancer, Ovarian Cancer, Colorectal … , Non-small Cell Lung Cancer, Ovarian Cancer, Colorectal … 4642 + Gemcitabine + Albumin-bound Paclitaxel, DUPERT (Fulzerasib/GFH925) … Cell Lung Cancer Market Non-small Cell Lung Cancer Market …
-
<![CDATA[Investigational PD-L1 x VEGF-A Bispecific Antibody Demonstrates Strong Overall Response Rate in Phase II Small Cell Lung Cancer Trial]]>
11 Sep 2025 17:43 GMT
… cell lung cancer is the most aggressive type of lung cancer with … in combination with either paclitaxel or topotecan for … than non-small cell lung cancer. Lung cancer is the second most … Patients With Small-cell Lung Cancer in Combination With Chemotherapy …
-
First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity
08 Sep 2025 15:00 GMT
… Lung Cancer in Barcelona. “Small cell lung cancer is the most aggressive type of lung cancer … -stage small cell lung cancer (Cohort 1) … of pumitamig plus paclitaxel, or topotecan in … Lung Cancer
Small cell lung cancer (SCLC) accounts for 15% of all lung cancer …
-
Emerging Targets in Non-Small Cell Lung Cancer
06 Sep 2025 06:12 GMT
… lung cancer (NSCLC) represents approximately 85% of all lung cancer … non-small cell lung cancer: molecular mechanisms and … Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer … non-small cell lung cancer. Lung Cancer. 2023;182:107291 …
-
With Summit leading the pack in PD-1xVEGF bispecifics, Pfizer lays out its own plan to replace Keytruda
12 Nov 2025 05:53 GMT
… first-line non-small cell lung cancer. The study, which will enroll … partner was nab-paclitaxel and 37.5% when paclitaxel was the combo … -line extensive-stage small cell lung cancer, a field where BioNTech and …
About
© 1995-2025